StockData

American Well vs Phreesia

AMWL and PHR side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How AMWL and PHR compare

Phreesia is the larger company, worth 3.9 times as much as American Well ($788M against $200M).

Phreesia grew revenue faster over the last twelve months (12.9% versus −19.0% for American Well).

Phreesia keeps more of each dollar of sales as profit, with a net margin of 2.1% compared with −35.7% at American Well.

American Well scores higher on the StockData Score (11 against 8 for Phreesia), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricAMWLPHR
Size and price
Market cap$200M$788M
Share price$11.74$12.69
Change, 1 year186%−45.2%
Change, 5 years−92.0%−81.3%
Beta (5Y)1.981.53
Employees5621,789
StockData Score
Total score11 (better)8
Valuation score3 (better)1
Growth score23 (better)
Performance score11
Health score5 (better)3
Dividend score00
Valuation
P/E–74.6×
P/S0.9× (better)1.6×
P/B0.9× (better)2.1×
EV/EBITDA–15.7×
P/FCF–9.8×
FCF yield−13.2%10.3% (better)
Fair value$18.20$9.67
Margin of safety35.5% (better)−31.3%
Growth
Revenue growth (TTM)−19.0%12.9% (better)
Revenue growth, 5Y average0.33%26.4% (better)
Profitability
Gross margin51.9%85.4% (better)
Operating margin−37.3%2.5% (better)
Net margin−35.7%2.1% (better)
FCF margin−12.1%15.9% (better)
Return on equity−31.0%3.1% (better)
Return on invested capital−145%4.4% (better)
Financial health
Debt / equity0.000.18 (better)
Net debt / EBITDA–−0.16
Interest coverage–1.2×
Current ratio2.90 (better)1.76
Altman Z-score−7.141.05 (better)
Piotroski F-score66
Dividends and buybacks
Buyback yield0.00%–
Shareholder yield0.00% (better)0.00%
Ownership
Held by institutions42.3%94.0%
Held by insiders15.8%22.7%
Insider net buying, 12 months−$1.0M$26.8M (better)
Short interest, % of float1.7%6.3%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.